Please provide your email address to receive an email when new articles are posted on . Amitriptyline was superior to placebo and increased the odds of relief from IBS symptoms. Researchers noted that ...

Irritable Bowel Syndrome (IBS) is a complex and often frustrating condition affecting millions worldwide. Finding effective treatments can be challenging, but a recent clinical trial has shed light on ...

GLASGOW, United Kingdom ― Amitriptyline, titrated at low dose, was superior to placebo as a second-line treatment for irritable bowel syndrome (IBS) across multiple outcomes in what the researchers ...

Titrated low-dose amitriptyline significantly improved irritable bowel syndrome (IBS) symptoms when used as a second-line treatment in the primary care setting, the randomized ATLANTIS trial showed.

Despite amitriptyline missing the primary endpoint of significantly improving pain relief, disability, and work-related outcomes at 6 months for people with chronic low back pain, shorter term ...